Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pelthos Therapeutics (PTHS) Share-based Compensation (2024 - 2025)

Pelthos Therapeutics has reported Share-based Compensation over the past 2 years, most recently at $1.8 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $1.8 million for Q4 2025, up 239.43% from a year ago — trailing twelve months through Dec 2025 was $5.5 million (up 220.64% YoY), and the annual figure for FY2025 was $5.5 million, up 203.56%.
  • Share-based Compensation for Q4 2025 was $1.8 million at Pelthos Therapeutics, down from $2.8 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PTHS hit a ceiling of $2.8 million in Q3 2025 and a floor of $292552.0 in Q1 2024.